- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Alemtuzumab – July 2014
ALEMTUZUMAB, solution for infusion, 10 mg/ mL, Lemtrada®, Genzyme (Sanofi-Aventis Australia Pty Ltd)
Last updated
8 November 2023